Cargando…

Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease

OBJECTIVE: To identify the prevalence of stage B heart failure (SBHF) in patients with type 2 diabetes mellitus (T2DM) with no history of cardiovascular disease (CVD). DESIGN: Observational study. SETTING: A single-centre study in which eligible patients were recruited from T2DM clinic. Following co...

Descripción completa

Detalles Bibliográficos
Autores principales: Oo, Mon Myat, Tan Chung Zhen, Isaiah, Ng, Kee Seong, Tan, Kok Leng, Tan, Alexander T B, Vethakkan, Shireene Ratna, A/L Ratnasingam, R Jeyakantha, Chee, Kok Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825254/
https://www.ncbi.nlm.nih.gov/pubmed/33478961
http://dx.doi.org/10.1136/bmjopen-2020-039869
_version_ 1783640264585248768
author Oo, Mon Myat
Tan Chung Zhen, Isaiah
Ng, Kee Seong
Tan, Kok Leng
Tan, Alexander T B
Vethakkan, Shireene Ratna
A/L Ratnasingam, R Jeyakantha
Chee, Kok Han
author_facet Oo, Mon Myat
Tan Chung Zhen, Isaiah
Ng, Kee Seong
Tan, Kok Leng
Tan, Alexander T B
Vethakkan, Shireene Ratna
A/L Ratnasingam, R Jeyakantha
Chee, Kok Han
author_sort Oo, Mon Myat
collection PubMed
description OBJECTIVE: To identify the prevalence of stage B heart failure (SBHF) in patients with type 2 diabetes mellitus (T2DM) with no history of cardiovascular disease (CVD). DESIGN: Observational study. SETTING: A single-centre study in which eligible patients were recruited from T2DM clinic. Following consent, patients completed a questionnaire and underwent physical examinations. Patients had blood drawn for laboratory investigations and had a transthoracic echocardiography. PARTICIPANTS: A total of 305 patients who were not known to have CVD were recruited. Patients with deranged liver function tests and end stage renal failure were excluded. MAIN OUTCOME MEASURES: Echocardiographic parameters such as left ventricular ejection fraction, left ventricular mass index (LVMI), left ventricular hypertrophy, left atrial enlargement and diastolic function were examined. RESULTS: A total of 305 patients predominantly females (65%), with mean body mass index of 27.5 kg/m(2) participated in this study. None of them had either a history or signs and symptoms of CVD. Seventy-seven percent of patients had a history of hypertension and 83% of this study population had T2DM for more than 10 years. Mean HbA1c of 8.3% was recorded. Almost all patients were taking metformin. Approximately, 40% of patients were on newer anti-T2DM agents such as sodium-glucose cotransporter-2 and dipeptidyl peptidase 4 inhibitors. Fifty-seven percent (n=174) of the study population had SBHF at the time of study: diastolic dysfunction, increased LVMI and increased left atrial volume index (LAVI) were noted in 51 patients (17%), 128 patients (42%) and 98 patients (32%), respectively. Thirty-seven patients (12%) had both increase LVMI and LAVI. CONCLUSION: Our study has revealed a high prevalence of SBHF in T2DM patients without overt cardiac disease in Malaysia that has one of the highest prevalence of TDM in the world.
format Online
Article
Text
id pubmed-7825254
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78252542021-01-29 Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease Oo, Mon Myat Tan Chung Zhen, Isaiah Ng, Kee Seong Tan, Kok Leng Tan, Alexander T B Vethakkan, Shireene Ratna A/L Ratnasingam, R Jeyakantha Chee, Kok Han BMJ Open Cardiovascular Medicine OBJECTIVE: To identify the prevalence of stage B heart failure (SBHF) in patients with type 2 diabetes mellitus (T2DM) with no history of cardiovascular disease (CVD). DESIGN: Observational study. SETTING: A single-centre study in which eligible patients were recruited from T2DM clinic. Following consent, patients completed a questionnaire and underwent physical examinations. Patients had blood drawn for laboratory investigations and had a transthoracic echocardiography. PARTICIPANTS: A total of 305 patients who were not known to have CVD were recruited. Patients with deranged liver function tests and end stage renal failure were excluded. MAIN OUTCOME MEASURES: Echocardiographic parameters such as left ventricular ejection fraction, left ventricular mass index (LVMI), left ventricular hypertrophy, left atrial enlargement and diastolic function were examined. RESULTS: A total of 305 patients predominantly females (65%), with mean body mass index of 27.5 kg/m(2) participated in this study. None of them had either a history or signs and symptoms of CVD. Seventy-seven percent of patients had a history of hypertension and 83% of this study population had T2DM for more than 10 years. Mean HbA1c of 8.3% was recorded. Almost all patients were taking metformin. Approximately, 40% of patients were on newer anti-T2DM agents such as sodium-glucose cotransporter-2 and dipeptidyl peptidase 4 inhibitors. Fifty-seven percent (n=174) of the study population had SBHF at the time of study: diastolic dysfunction, increased LVMI and increased left atrial volume index (LAVI) were noted in 51 patients (17%), 128 patients (42%) and 98 patients (32%), respectively. Thirty-seven patients (12%) had both increase LVMI and LAVI. CONCLUSION: Our study has revealed a high prevalence of SBHF in T2DM patients without overt cardiac disease in Malaysia that has one of the highest prevalence of TDM in the world. BMJ Publishing Group 2021-01-21 /pmc/articles/PMC7825254/ /pubmed/33478961 http://dx.doi.org/10.1136/bmjopen-2020-039869 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Oo, Mon Myat
Tan Chung Zhen, Isaiah
Ng, Kee Seong
Tan, Kok Leng
Tan, Alexander T B
Vethakkan, Shireene Ratna
A/L Ratnasingam, R Jeyakantha
Chee, Kok Han
Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title_full Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title_fullStr Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title_full_unstemmed Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title_short Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
title_sort observational study investigating the prevalence of asymptomatic stage b heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825254/
https://www.ncbi.nlm.nih.gov/pubmed/33478961
http://dx.doi.org/10.1136/bmjopen-2020-039869
work_keys_str_mv AT oomonmyat observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT tanchungzhenisaiah observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT ngkeeseong observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT tankokleng observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT tanalexandertb observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT vethakkanshireeneratna observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT alratnasingamrjeyakantha observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease
AT cheekokhan observationalstudyinvestigatingtheprevalenceofasymptomaticstagebheartfailureinpatientswithtype2diabeteswhoarenotknowntohavecoronaryarterydisease